How China Became the Biotech Industry’s Back-Office

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
Nature

China’s shift towards ‘organized research’: how can coordination and innovation co-exist?

ing Xie is a lecturer at the School of Marxism Studies, Zhejiang University of Finance and Economics, Hangzhou, Zhejiang, China. In the past two decades, China has made big advances in scientific ...

China's Atomic Energy Law, taking effect Thursday, is set to boost high-quality development of nuclear power: expert

A view of the Experimental Advanced Superconducting Tokamak (EAST), dubbed China's "artificial sun," in Hefei, East China's ...
The Diplomat

When Will China Begin Earning Nobel Prizes in Science?

China’s rise in science has been even more dramatic than its rapid economic development. China and the United States currently spend far more on research and development and publish significantly more ...
The Diplomat

China’s Development Strategy in the 15th Five-Year Plan Era

The recently concluded Fourth Plenum Session of the Communist Party of China approved the draft proposal for the 15th Five-Year Plan, setting the strategic direction for China’s next stage of ...
FierceBiotech

China proposes shorter clinical trial reviews in efforts to accelerate drug development

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time regulators take to review clinical trials. In a draft policy posted (Chinese ...